Sign in
TerminatedPhase 4

Effect of Continuing Versus Holding Metformin During Hospitalizations.

Key facts

Who runs it
University of Illinois Chicago
Where
Chicago, United StatesSee the site
Trial code
Status
Terminated
Phase
Phase 4
People taking part
22 people enrolled
Started
21 Jan 2025
Ended
30 Apr 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Metformin
Record updated
17 June 2026
Why it stopped
Low recruitment rate and an inability to meet power.

Who can take part

Age
18 years to 110 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Adult (18+ years of age)
  • Admitted to an internal medicine service
  • On Metformin prior to admission

Who cannot take part

  • Inability to take oral medications
  • Acute Decompensated Heart Failure
  • eGFR < 30 ml/min/1.73 m2
  • Dialysis
  • Current Acidosis (pH < 7.35) including diabetic ketoacidosis
  • Child-Turcotte-Pugh class C hepatic cirrhosis
  • Cognitively impaired and/or unable to consent
  • Lack of or unwillingness to share contact information
  • Pregnant women

Where in United States

  • University of Illinois at ChicagoChicago, United States

About the trial

What the trial wants to find out

A randomized study of continuing versus holding metformin during hospitalizations to internal medicine services to determine the effects on glucose control, acidosis, abdominal symptoms, length of stay, and mortality.

The 2 groups in the trial

  • Metformin continuationExisting treatment, for comparison

    Continuation of home metformin regimen during hospitalization to an internal medicine service

    Treatment: Metformin

  • Metformin discontinuationNo study treatment, for comparison

    Holding home metformin regimen during hospitalization to an internal medicine service

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Continuing Versus Holding Metformin During Hospitalizations to Internal Medicine on Glucose Control, Acidosis, Abdominal Symptoms, Length of Stay, and Mortality.
Record updated
17 June 2026